Merck’s Covid-19 Pill Was 30% Effective in Final Analysis, Company Says
Published
An experimental Covid-19 pill from Merck and partner Ridgeback was 30% effective in a final analysis of study results, the companies said, down from the 50% rate found in an earlier look.
#ridgeback #merck #covid19pill